Sunil Healthcare Adjusts Stock Evaluation Amid Mixed Financial Performance Indicators
Sunil Healthcare, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation, reflecting changes in underlying trends. The company reported strong first-quarter performance for FY25-26, with notable operating profit metrics, though it faces challenges such as high debt levels and modest long-term growth.
Sunil Healthcare, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects changes in its underlying trends. The stock's score has been revised, indicating a shift in its technical outlook. Key financial metrics reveal that Sunil Healthcare reported a positive performance in the first quarter of FY25-26, with an operating profit to interest ratio reaching 2.28 times, marking a significant achievement. The company also recorded its highest PBDIT at Rs 3.28 crore and an operating profit to net sales ratio of 14.49%. Despite these positive indicators, the stock has faced challenges over the longer term, with a modest average return on capital employed (ROCE) of 5.38% and a relatively low annual growth rate in net sales of 2.85% over the past five years.
The stock is currently trading at a discount compared to its peers' average historical valuations, which may attract attention. However, the company also grapples with a high debt to EBITDA ratio of 6.67 times, indicating potential concerns regarding its ability to service debt.
For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
